NO985414L - Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt - Google Patents

Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt

Info

Publication number
NO985414L
NO985414L NO985414A NO985414A NO985414L NO 985414 L NO985414 L NO 985414L NO 985414 A NO985414 A NO 985414A NO 985414 A NO985414 A NO 985414A NO 985414 L NO985414 L NO 985414L
Authority
NO
Norway
Prior art keywords
sodium
salt
containing potassium
pharmaceutical
trioxaprozin
Prior art date
Application number
NO985414A
Other languages
English (en)
Norwegian (no)
Other versions
NO985414D0 (no
Inventor
Mark E Adams
Subhash Desai
Aziz Karim
Kalidas Paul
Douglas J Schaaf
David J Zold
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of NO985414D0 publication Critical patent/NO985414D0/no
Publication of NO985414L publication Critical patent/NO985414L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
NO985414A 1996-05-20 1998-11-20 Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt NO985414L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1903396P 1996-05-20 1996-05-20
PCT/US1997/007637 WO1997044022A1 (en) 1996-05-20 1997-05-14 Potassium, sodium and tris oxaprozin salt pharmaceutical formulations

Publications (2)

Publication Number Publication Date
NO985414D0 NO985414D0 (no) 1998-11-20
NO985414L true NO985414L (no) 1999-01-19

Family

ID=21791076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985414A NO985414L (no) 1996-05-20 1998-11-20 Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt

Country Status (20)

Country Link
US (1) US6030643A (de)
EP (1) EP0901372B1 (de)
JP (1) JP4185974B2 (de)
KR (1) KR20000015865A (de)
CN (1) CN1129429C (de)
AT (1) ATE299699T1 (de)
AU (1) AU718030B2 (de)
BR (1) BR9710448A (de)
CA (1) CA2255064C (de)
CZ (1) CZ370298A3 (de)
DE (1) DE69733752T2 (de)
ES (1) ES2248850T3 (de)
IL (1) IL126998A (de)
NO (1) NO985414L (de)
NZ (1) NZ332861A (de)
PL (1) PL330145A1 (de)
RU (1) RU2197244C2 (de)
TW (1) TW586929B (de)
WO (1) WO1997044022A1 (de)
ZA (1) ZA974366B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022939A1 (en) * 1999-09-29 2001-04-05 Fmc Corporation Hydrolyzed cellulose granulations of salts of drugs
US6497157B1 (en) * 1999-11-29 2002-12-24 Distek, Inc. Intrinsic dissolution apparatus with stationary sample holder
FR2828810B1 (fr) * 2001-08-27 2005-10-07 Lvmh Rech Composition cosmetique a effet tenseur contenant un polymere d'origine naturelle et un agent hydratant polyhydroxyle
KR100574554B1 (ko) * 2004-05-28 2006-04-27 한미약품 주식회사 니아신의 경구투여용 서방성 조성물
AU2006228869A1 (en) * 2005-03-30 2006-10-05 Astion Pharma A/S Oxaprozin or a closely related compound for the treatment of eczema
UY29449A1 (es) * 2005-03-30 2006-10-02 Astion Dev As Tratamiento de enfermedades dermatólogicas y del prurito.
US20060276537A1 (en) * 2005-06-01 2006-12-07 Tamar Goren Use of ladostigil for the treatment of multiple sclerosis
PE20081734A1 (es) 2007-02-01 2009-01-19 Takeda Pharmaceutical Comprimido que comprende 2-[[6-[(3r)-3-amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-benzonitrilo y celulosa microcristalina
SG11201405353VA (en) * 2012-03-22 2014-09-26 Transtech Pharma Llc Tris(hydroxymethyl)aminomethane salts of a small-molecule glp1r agonist and pharmaceutical compositions and uses thereof
EP3275433A1 (de) 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Zusammensetzung mit verzögerter freisetzung mit mikronisiertem tolcapon

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts
US4190584A (en) * 1976-08-13 1980-02-26 John Wyeth & Brother Limited Process for preparing oxazoles
GB2097389B (en) * 1981-04-28 1984-11-28 Wyeth John & Brother Ltd Oxazole derivative
IE52909B1 (en) * 1981-04-28 1988-04-13 Wyeth John & Brother Ltd Oxazole derivatives
US4385049A (en) * 1981-05-12 1983-05-24 K-V Pharmaceutical Company Stable high internal phase ratio topical emulsions
US4599359A (en) * 1982-12-09 1986-07-08 Stephen A. Cooper Hydroxyzine-containing analgesic combinations
GB8329326D0 (en) * 1983-11-03 1983-12-07 Wyeth John & Brother Ltd Oxazole derivatives
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
GB8630273D0 (en) * 1986-12-18 1987-01-28 Til Medical Ltd Pharmaceutical delivery systems
US5059626A (en) * 1988-07-25 1991-10-22 Applied Analytical Industries, Inc. Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs
CA2058975C (en) * 1990-10-30 2000-06-06 Shuichi Kasai Antiinflammatory gel preparation
WO1995007103A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
WO1995007079A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine

Also Published As

Publication number Publication date
DE69733752D1 (de) 2005-08-25
WO1997044022A1 (en) 1997-11-27
RU2197244C2 (ru) 2003-01-27
ZA974366B (en) 1998-05-20
TW586929B (en) 2004-05-11
PL330145A1 (en) 1999-04-26
US6030643A (en) 2000-02-29
CN1129429C (zh) 2003-12-03
ATE299699T1 (de) 2005-08-15
KR20000015865A (ko) 2000-03-15
BR9710448A (pt) 1999-08-17
CA2255064A1 (en) 1997-11-27
CZ370298A3 (cs) 1999-05-12
NZ332861A (en) 2000-08-25
IL126998A0 (en) 1999-09-22
JP4185974B2 (ja) 2008-11-26
CN1225580A (zh) 1999-08-11
EP0901372A1 (de) 1999-03-17
CA2255064C (en) 2006-10-10
JP2001503734A (ja) 2001-03-21
IL126998A (en) 2003-12-10
NO985414D0 (no) 1998-11-20
AU3059797A (en) 1997-12-09
ES2248850T3 (es) 2006-03-16
EP0901372B1 (de) 2005-07-20
DE69733752T2 (de) 2006-06-01
AU718030B2 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
EA199800772A1 (ru) Производные 6-фенилпиридил-2-амина
EE04111B1 (et) Raku adhesiooni inhibiitorid, nende kasutamine janeid sisaldavad farmatseutilised kompositsioonid
DE69432984D1 (de) Therapeutische substituierte guanidine
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
IL218087A0 (en) Anti-ngf antibodies, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments for the treatment of pain
FI962154A (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
SG124234A1 (en) Cell adhesion inhibitors
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
DE69905170T2 (de) Thiazolopyrimidinderivate
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
NO985414L (no) Farmas÷ytiske formuleringer inneholdende kalium-, natrium- og trioksaprozin salt
YU13301A (sh) Muskarinski agonisti i antagonisti
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
EE9900470A (et) Tsinkhüaluronaadi kasutamine peptilise haavandi vastu
SE9802937D0 (sv) Novel compounds
NZ330944A (en) Peptide derivatives
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
AU9731198A (en) Histogranin peptide and their analgesic use
GR850831B (de)
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
PT934342E (pt) Composicao contendo quitosano
MX9802809A (es) Ureasa para el tratamiento de infecciones de helicobacter pylori.
PT980379E (pt) Oligonucleotidos quimericos e sua utilizacao
IT1255678B (it) Composizioni farmaceutiche per la somministrazione di paratormone, suoi frammenti biologicamente attivi o peptidi correlati per via rettale.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application